drugset / Trial / NCT02182570
WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients
NaSingle-groupOpen-labelTreatment
Summary
The safety and efficacy of WAL 801 CL (epinastine hydrochloride) Dry Syrup in the treatment of atopic dermatitis in children was evaluated and plasma drug concentrations were measured.
Timeline
- Start
- 2001-06
- Primary completion
- 2002-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epinastine | Small molecule | — | — |